Hospira Inc will be manufacturing seven Genzyme drugs over a span of the next 5 years. The deal will be ending on June 30, 2015. The drugs are Cerezyme, Fabrazyme, Myozyme, Lumizyme, Thyrogen, Thymoglobulin, and Campath. Genzyme in May gave back $175 million of its profits which were deemed as unlawful because of contamination problems [...]